Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- News from the world of Education: September 25, 2025
- Choosing The Right Real Estate Developer Is No Cakewalk. Here Is An Easy Guide
- Stress on industry due to Covid-19 to extend beyond Q1 of FY21, more firms willing to retain manpower: ASSOCHAM Survey
- China rules the $94-trillion global infrastructure market. India wants a share of the pie
